ISSN 1662-4009 (online)

ey0021.10-5 | Important for Clinical Practice | ESPEYB21

10.5. Equitable implementation of a precision digital health program for glucose management in individuals with newly diagnosed type 1 diabetes

P Prahalad , D Scheinker , M Desai , VY Ding , FK Bishop , MY Lee , al. et

Brief Summary: This prospective, pragmatic, open-label study assessed the impact of a systematic and equitable digital-health-team-based care program designed to achieve tight glycemic targets (HbA1c <7%) through early technology use and remote patient monitoring, in young people with newly diagnosed T1D. The program was successful: 68% of participants achieved target HbA1c, and an average 65% time in glucose range at one-year post-diagnosis.Despite ...

ey0019.13-10 | Diabetes | ESPEYB19

13.10. Hemoglobin A1c trajectories in the first 18 months after diabetes diagnosis in the SWEET diabetes registry

P Prahalad , A Schwandt , S Besancon , M Mohan , B Obermannova , M Kershaw , R Bonfanti , A Pundziute Lycka , R Hanas , K Casteels , the SWEET Study Group

prahalad@stanford.edu Pediatr Diabetes 2022; 23: 228–236. doi: 10.1111/pedi.13278Brief Summary: Analysis of the multi-national SWEET diabetes registry showed that mean HbA1c in youth is highest at diagnosis and lowest at 4 to 5 months post-diagnosis. The HbA1c trajectory was lower in countries with nationalized health insurance. High gross domestic p...